东方生物：“肺炎支原体抗原检测试剂盒（乳胶法）”等产品取得注册证

Company Overview - Oriental Bio (SH 688298) announced on November 14 that Zhejiang Oriental Gene Biological Products Co., Ltd. and its subsidiary Hangzhou Laihe Biotechnology Co., Ltd. have obtained registration certificates for several medical device products, including the "Mycoplasma pneumoniae antigen detection kit (latex method)" [1] Financial Performance - For the year 2024, Oriental Bio's revenue composition is projected to be 97.99% from the in vitro diagnostic industry and 2.01% from other businesses [1] - As of the report date, Oriental Bio has a market capitalization of 5.7 billion yuan [1]